Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
LGM Pharma announced an investment of over $6 million to expand its Rosenberg, Texas manufacturing facility as part of its Phase I CDMO growth strategy. The expansion will increase capacity for liquid, suspension, semi-solid, and suppository drug ...
read more
LGM Pharma has announced the second phase of its CDMO growth strategy, committing an additional $9 million to its drug product manufacturing facilities in Rosenberg, Texas, and Colorado Springs, Colorado.
read more
Thursday, October 17, 2024
LGM Pharma announced the expansion of its Analytical Testing Services (ATS) with the addition of endotoxin and rapid sterility testing capabilities. These new services, now available at LGM Pharma’s Irvine, CA facility, offer significant benefits to ...
read more
Tuesday, October 15, 2024
LGM Pharma announced the expansion of its Analytical Testing Services (ATS) with the addition of endotoxin and rapid sterility testing capabilities. These new services, now available at LGM Pharma’s Irvine, CA facility, offer significant benefits to ...
read more
LGM Pharma has acquired the formulation development and drug product contract manufacturing business of Nexgen Pharma.
read more
Tuesday, September 09, 2025
LGC Group opened its new Organic Chemistry Synthesis Centre of Excellence in Vaughan, Ontario, following a CAD $100 million investment. The 203,000 ft² (17,200 m²) facility is one of the largest of its kind in the world and significantly expands ...
read more
LGC announced the acquisition of a majority stake in Toronto Research Chemicals, a manufacturer and supplier of synthetic organic bio-chemicals.
read more
LGC has announced the acquisition of The Native Antigen Company (NAC), a supplier of infectious disease antigens and antibodies.
read more
Monday, November 26, 2018
LGC announced the acquisition of SeraCare Life Sciences, a manufacturer and partner to global in vitro diagnostics manufacturers and clinical laboratories.
read more
LG Chem and AVEO Oncology, an LG Chem company, announced that it has enrolled the first patient in the United States for a Phase 1 clinical study of LB-LR1109 (NCT06332755; LG project code LR19155), LG Chem's first proprietary anti-cancer ...
read more
LFB American Plasma LLC, an LFB Group company, and ImmunoTek BioCenters LLC, have announced an agreement on the supply of plasma collected in the USA. The newly set up United States subsidiary of the French biopharmaceutical company is a further step...
read more
Tuesday, February 25, 2020
Levadura Biotechnology has received the ISR for Levadura’s first Patent Cooperation Treaty patent application.
read more
Thursday, December 02, 2021
Leucid Bio a biotech company pioneering next-generation cell therapies for hard-to-treat cancers, today announces that it has entered a strategic collaboration with Lonza to utilize Lonza's Cocoon® Platform for the Company's forthcoming Phase I ...
read more
Monday, December 07, 2020
leon-nano Drugs GmbH has announced the appointment of Dr. Robert Becker as an Independent Board Member to the company’s Supervisory Board.
read more
Wednesday, March 06, 2019
LEO Science & Tech Hub announced the appointment of Vladimir Morozov, Ph.D., as Senior Director of Bioinformatics.
read more